Delisting of Zeda (688555.SH): The stock was terminated and delisted by the Shanghai Stock Exchange on July 7
On May 31, 2023, it was announced that the company received the Self-Regulatory Decision [2023] No. 117 “Decision on the Termination of the Listing of Zeda Yisheng (Tianjin) Technology Co., Ltd. Shares” issued by the Shanghai Stock Exchange on May 31, 2023. The Shanghai Stock Exchange decided to terminate the listing of the company's shares. 688555.SH The stock entered the delisting period on June 8, 2023. As of June 30, 2023, the company's shares have been traded for 15 trading days during the delisting period, and the delisting period has ended. It will end on July 7, 2023 by the Shanghai Stock Exchange
Essence Information Technology (SHSE:688555 Investor One-year Losses Grow to 70% as the Stock Sheds CN¥413m This Past Week
Even the best investor on earth makes unsuccessful investments. But it's not unreasonable to try to avoid truly shocking capital losses. So spare a thought for the long term shareholders of Essence
Essence Information Technology's (SHSE:688555) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Essence Information Technology Co., Ltd.'s (SHSE:688555) recent weak earnings report didn't cause a big stock movement. We think that investors are worried about some weaknesses underlying the earni
Zeda Yisheng: 18 institutions, including CITIC and Huachuang Securities, investigated our company on December 21.
Zeda Yi Sheng (688555) issued a notice on January 10, 2022: CITIC, Huachuang Securities, CSC FINANCIAL CO.,LTD, Western profit Fund, Ping an Capital Management, CITIC Prudential plc Fund, Guolianan Fund, Oriental Alpha Fund, Finance Fund, Huitianfu Fund, Industrial Fund, Jianxin Fund, Tianhong Fund, Soochow Fund, China Finance Fund, HSBC Jinxin Fund, Guohua Life Insurance, Pacific Insurance investigated our company on December 21, 2021. The main content of this survey: Q: excuse me, what are your company's advantages in the research and development of formula particles? What are the company's customers in traditional Chinese medicine slices and granules? Answer: male
Zhongyuan Securities: 1.3% loss of gold stock portfolio in December the list of recommended stocks was released in January.
In January, the gold stocks recommended by Zhongyuan Securities are: Huali Science and Technology, Ping An Insurance, Midea, China Energy Construction, Salt Lake shares, Jinhe Industry, Zeda Yisheng, Jiuyuan Yinhai, Dashenlin, Guangqi Technology. [gold stocks Review] in December 2021, the gold stock portfolio recommended by Zhongyuan Securities lost 1.3%, ranking 19th among 31 brokerages. The three stocks with the highest returns were Huikang, Xinhai Technology, and Dongfang Electric, respectively, with monthly increases of 15.98%, 6.61% and 5%, respectively. For details of the report, see "the record of brokerage gold stock portfolio in December": 9.26% of Chuancai Securities won the title and Soochow was the worst.
Zeda Yi Sheng (688555.SH): Xinchen Investment plans to reduce its stake by no more than 2%
688555.SH announced that on December 28, 2021, the company received a "notification letter" from Xinchen Investment on its share reduction plan. Xinchen Investment plans to reduce its holdings by centralized bidding within 6 months after 15 trading days from the date of the announcement, accounting for no more than 2% of the company's total share capital, accounting for no more than 2% of the company's total share capital. For 90 consecutive natural days, the shares of the company shall be reduced by means of centralized bidding transaction not more than 831100 shares, and the proportion of the reduced shares in the total share capital of the company shall not exceed 1%.
Zeda Yi Sheng's latest announcement: shareholder Xinchen Investment intends to reduce its stake by no more than 2%.
Zeda Yi Sheng announced that shareholder Xinchen Investment intends to reduce its stake by no more than 2%. The chairman of the company is Lin Ying. Ms. Lin Ying: born in January 1973, Chinese nationality, Ph. D. degree, vice president of Zhejiang Zhejiang University Wangxin Group Co., Ltd., from December 2008 to December 2014, founded Yisheng Co., Ltd. Chairman of the board in January 2013; director and general manager of the company from March 2016 to September 2017; chairman and general manager of the company since September 2017. This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If you have any questions, please contact us.
Zeda Yi Sheng (688555.SH) shareholder Xinchen Investment plans to reduce its holdings of no more than 1.6622 million shares
Zida Yisheng (688555.SH) announced that on December 28, 2021, the company received a "notification letter" from Xinchen Investment on its share reduction plan. Within 6 months after 15 trading days from the date of the announcement, Xinchen Investment plans to reduce its holdings by means of centralized bidding, accounting for no more than 1.6622 million shares, accounting for less than 2% of the company's total share capital. For 90 consecutive natural days, the shares of the company shall be reduced by means of centralized bidding transaction not more than 831100 shares, and the proportion of the reduced shares in the total share capital of the company shall not exceed 1%.
Entrusted financial management has attracted attention, and Zeda Yisheng (688555.SH) has received a letter of inquiry from the Shanghai Stock Exchange.
Zhitong Financial APP learned that on December 27th, the Shanghai Stock Exchange sent a letter of inquiry to 688555.SH. According to the inquiry letter, the company submitted the Progress announcement on entrusted Financial Management on December 27, 2021, saying that the company and its subsidiaries signed an asset management contract with Xinyuan Asset Management Co., Ltd. in November and December 2020. the total amount of entrusted financial management is 5 billion yuan. In this regard, the Shanghai Stock Exchange asked Zeda Yisheng to verify and disclose the specific time, personnel, main terms and violations of the 5 billion yuan entrusted financial management contract signed between the company and its subsidiaries and Xinyuan Asset Management Co., Ltd.
There are no major undisclosed matters about the changes in the share price of 688555.SH.
Zhitong Financial APP News, Zeda Yisheng (688555.SH) issued an announcement that the company's shares closed at a daily price deviation of more than 30% in three consecutive trading days on December 23, December 24 and December 27, 2021. According to the relevant provisions of the Shanghai Stock Exchange Trading rules, the Shanghai Stock Exchange Science and Technology Innovation Board Stock Trading Special regulations, and the Shanghai Stock Exchange Science and Technology Innovation Board Stock Exchange Real-time Monitoring rules for abnormal Stock Trading (for trial implementation), it belongs to the abnormal fluctuation of stock trading. Verified by the company's self-examination and written letter to the actual controller, as of the date of disclosure of the announcement, it does not exist.
[dynamic stocks] traditional Chinese medicine concept plate pulled up, Longshen Rongfa (300534.CN) rose 20.0%
[Caihua Social News] by midday today, as of 13:15, the concept plate of traditional Chinese medicine had been pulled up. Longshen Rongfa (300534.CN) rose 20.00% to 11.76 yuan, Red Sun Pharmaceutical (300026.CN) 19.96% to 5.35 yuan, 300181.CN (300181.CN) 14.20% to 10.05 yuan, Xinguang Pharmaceutical (300519.CN) 12.59% to 19.68 yuan, Zeda Yisheng (688555.CN) 12.24% to 32.18 yuan, essence Pharmaceutical (002349.CN) up 10.06%.
Summary of the three quarterly reports on October 20: the announcements of Dabei Nong, Jinlei shares and other companies are unfavorable.
1. Dabei Nong: the net profit of the third quarter was 166.38% lower than that of the same period last year. According to the third quarterly report of Dabei Nong 2021, the company's main income was 23.442 billion yuan, up 53.55% from the same period last year; the net profit from its mother was 107 million yuan, down 92.76% from the same period last year; deducting non-net profit of-53.5147 million yuan, down 104.31% from the same period last year; of which in the third quarter of 2021, the company's main income per quarter was 8.173 billion yuan, up 30.26% from the same period last year. The net profit of returning to the mother in a single quarter-391.362 million yuan, down 166.38% from the same period last year; deducting non-net profit in a single quarter-
Zeda Yi Sheng's latest announcement: net profit in the third quarter was 9.7548 million yuan lower than the same period last year. 49.07%
Zeda Yisheng released a report for the third quarter of 2021, with operating income of 69.7943 million yuan, an increase of 26.63% over the same period last year. Net profit belonging to shareholders of listed companies was 9.7548 million yuan, down 49.07% from the same period last year; net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses was 8.1769 million yuan, down 49.45% from the same period last year; and basic earnings per share was 0.12 yuan. Zeda Yisheng 2021 China report showed that the company's main income was 142 million yuan, up 30.61% from the same period last year; the net profit from its mother was 26.4652 million yuan, down 11.56% from the same period last year; deducting non-net profit
No Data